Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case

被引：19
|
作者：
Connor, Bradley A. [1 ,2 ,3 ]
Couto-Rodriguez, Mara [4 ]
Barrows, Joseph E. [4 ]
Gardner, Morgan [2 ,3 ]
Rogova, Marina [2 ,3 ]
O'Hara, Niamh B. [4 ,5 ]
Nagy-Szakal, Dorottya [4 ,5 ]
机构：
[1] Weill Cornell Med, New York, NY 10021 USA
[2] New York Ctr Travel & Trop Med, New York, NY 10022 USA
[3] GeoSentinel, New York, NY 12201 USA
[4] Biotia Inc, New York, NY USA
[5] SUNY Downstate Hlth Sci Univ, Dept Cell Biol, Coll Med, New York, NY USA
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2021年 / 110卷
关键词：
B; 1; 617; 2; Delta variant; SARS-CoV-2; COVID-19; variant of concern; breakthrough; monoclonal antibody therapy; bamlanivimab; etesevimab;
D O I：
10.1016/j.ijid.2021.07.029
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
We present two Delta (B.1.617.2) vaccine breakthrough individuals, a father and son living in separate households. The older, 63-year-old patient's symptoms were severe enough to require hospitalization. De-spite having a high titer of anti-spike IgG in his serum, his symptoms resolved within 24 hours following monoclonal antibody (bamlanivimab/etesevimab) therapy. (c) 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页码：232 / 234
页数：3
相关论文
共 50 条
  • [41] Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021
    de Gier, Brechje
    Andeweg, Stijn
    Backer, Jantien A.
    Hahne, Susan J. M.
    van den Hof, Susan
    de Melker, Hester E.
    Knol, Mirjam J.
    EUROSURVEILLANCE, 2021, 26 (44)
  • [42] Genome Sequence of an Early Imported Case of SARS-CoV-2 Delta Variant (B.1.617.2 AY.122) in Iraq in April 2021
    Al-Rashedi, Nihad A. M.
    Alburkat, Hussein
    Munahi, Murad G.
    Jasim, Ali H.
    Salman, Batool Kadham
    Oda, Basel Saber
    Mossa, Abbas Abd-Alsahib
    Abbas, Ahmed Abdulrazzaq
    Vapalahti, Olli
    Sironen, Tarja
    Smura, Teemu
    MICROBIOLOGY RESOURCE ANNOUNCEMENTS, 2022, 11 (11):
  • [43] Guangdong's Study of the Effectiveness of China's Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant
    Wang, Fuzhen
    An, Zhijie
    Rodewald, Lance
    Wu, Dan
    Tang, Lin
    Zheng, Hui
    Liu, Qianqian
    Gao, George F.
    Yin, Zundong
    CHINA CDC WEEKLY, 2021, 3 (34): : 728 - 730
  • [44] A systematic review of Vaccine Breakthrough Infections SARS-CoV-2 Delta Variant
    Zhang, Mengxin
    Liang, Ying
    Yu, Dongsheng
    Du, Bang
    Cheng, Weyland
    Li, Lifeng
    Yu, Zhidan
    Luo, Shuying
    Zhang, Yaodong
    Wang, Huanmin
    Zhang, Xianwei
    Zhang, Wancun
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (02): : 889 - 900
  • [45] Detection of SARS-CoV-2 Delta Variant (B.1.617.2) in Domestic Dogs and Zoo Tigers in England and Jersey during 2021
    Seekings, Amanda H.
    Shipley, Rebecca
    Byrne, Alexander M. P.
    Shukla, Shweta
    Golding, Megan
    Amaya-Cuesta, Joan
    Goharriz, Hooman
    Vitores, Ana Gomez
    Lean, Fabian Z. X.
    James, Joe
    Nunez, Alejandro
    Breed, Alistair
    Frost, Andrew
    Balzer, Joerg
    Brown, Ian H.
    Brookes, Sharon M.
    McElhinney, Lorraine M.
    VIRUSES-BASEL, 2024, 16 (04):
  • [46] A Paradigm Shift in the Combination Changes of SARS-CoV-2 Variants and Increased Spread of Delta Variant (B.1.617.2) across the World
    Chakraborty, Chiranjib
    Sharma, Ashish Ranjan
    Bhattacharya, Manojit
    Agoramoorthy, Govindasamy
    Lee, Sang-Soo
    AGING AND DISEASE, 2022, 13 (03): : 927 - 942
  • [47] The SARS-CoV-2 Delta (B.1.617.2) variant with spike N501Y mutation in the shadow of Omicron emergence
    Salimovic-Besic, Irma
    Dedeic-Ljubovic, Amela
    Zahirovic, Edina
    Hasanovic, Medina
    Sehic, Merima
    Vukovikj, Maja
    Boshevska, Golubinka
    Vegar-Zubovic, Sandra
    Mehmedika-Suljic, Enra
    Izetbegovic, Sebija
    HELIYON, 2022, 8 (12)
  • [48] Transmission of SARS-CoV-2 Delta variant (B.1.617.2) from a fully vaccinated human to a canine in Georgia, July 2021
    Wendling, Natalie M.
    Carpenter, Ann
    Liew, Amanda
    Ghai, Ria R.
    Gallardo-Romero, Nadia
    Stoddard, Robyn A.
    Tao, Ying
    Zhang, Jing
    Retchless, Adam C.
    Ahmad, Ausaf
    Bunkley, Paige
    Godino, Claire
    Mauldin, Matthew R.
    Varela, Kate
    Ritter, Jana M.
    Hennebelle, Janemarie
    Feldpausch, Amanda
    Gabel, Julie
    Kainulainen, Markus H.
    Herzegh, Owen
    Tong, Suxiang
    Spengler, Jessica R.
    Barton Behravesh, Casey
    ZOONOSES AND PUBLIC HEALTH, 2022, 69 (05) : 587 - 592
  • [49] Olfactory dysfunction is more severe in wild-type SARS-CoV-2 infection than in the Delta variant (B.1.617.2)
    Klimek, Ludger
    Hagemann, Jan
    Hummel, Thomas
    Altundag, Aytug
    Hintschich, Constantin
    Stielow, Sabine
    Bousquet, Jean
    WORLD ALLERGY ORGANIZATION JOURNAL, 2022, 15 (06):
  • [50] Maternal and Perinatal Outcomes Associated With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta (B.1.617.2) Variant
    Seasely, Angela R.
    Blanchard, Christina T.
    Arora, Nitin
    Battarbee, Ashley N.
    Casey, Brian M.
    Dionne-Odom, Jodie
    Leal, Sixto M., Jr.
    Moates, Derek B.
    Sinkey, Rachel G.
    Szychowski, Jeff M.
    Tita, Alan T.
    Subramaniam, Akila
    OBSTETRICS AND GYNECOLOGY, 2021, 138 (06): : 842 - 844
12345